LRP6 and metastatic malignant neoplasm in the lymph nodes: 76.6% (59/77) of cases with lymph node metastasis was positive p-LRP6, but only 48.8% (39/80) (p<0.001, χ2=12.995) without metastasis showed p-LRP6 expression.